Newly issued guidance on the intent to delay enforcement of these key regulatory requirements under MoCRA for six months will allow cosmetics and personal care product companies more time to enact compliance measures.
In accordance with MoCRA, the FDA’s draft guidance document outlines recommendations to establish a new electronic submission system to replace the Voluntary Cosmetic Registration Program (VCRP) by the end of this year.
In our round up of the most popular articles from the recent business quarter, we’ve focused on news and trend developments in the North and South American beauty and personal care markets, including the FDA’s suspension of VCRP submissions, the launch...
The FDA opened a Listening Session for public commentary of the Good Manufacturing Practices section of MoCRA today with an open docket for commentary through July 3, 2023.
It wasn’t until 2020 that Coronavirus disease 2019 (COVID-19) became a factor of import in the cosmetics and personal care industry. But by now, no matter where in the world you are, the virus has changed things. Here Cosmetics Design looks at how our...
The US Food and Drug Administration has released draft guidelines on the safety of nanomaterials in cosmetic products, urging manufacturers to meet with it before incorporating the ingredients into formulations, to substantiate the product’s safety.
Investing in having formulations and labels reviewed to ensure they only use permissible color additives, as well as ensuring ingredients are named correctly on the label can save cosmetics manufacturers and importers a lot of time, stress and money,...
The U.S. Food and Drug Administration's newly released sunscreen rules do not sufficiently consider the risks posed by nanoscale ingredients according to some public interest groups, leading them to label the latest announcement 'disappointing.
Canadian life sciences and technology company Botaneco has announced the compliance of its oleosome-based sunscreen formulation with the FDA sunscreen monograph, which can now be marketed in the US with an SPF 30 claim.
Allergan’s online promotional materials for its eyelash enhancer Latisse do not adequately show the potential risks of the product, according to the US Food and Drug Administration.
Lead can be found in small quantities in lipsticks but the levels are well below those recommended by international regulatory authorities, according to the Personal Care Products Council (PCPC).
The approval of an eyelash enhancing prescription drug from Allergan suggests the time has come to clarify the difference between a cosmetic and a drug.
Former presidential candidate John Kerry is leading an attack on
the US Food and Drug Administration (FDA), criticizing the
regulatory body for failing to respond to the potential health
hazard of lead in lipsticks.
The US House of Appropriations is debating a bill to increase
funding for the Office of Cosmetics and Colors; an increase that
may be much needed as products containing nanotechnology and
cosmeceuticals increase.
In light of the recent scare over poisonous chemicals found in
toothpaste exports from China, the US Food and Drug Administration
has advised consumers to avoid buying any toothpaste labeled as
made in China.
US Food and Drug Administration (FDA) officials have this month
approved the sales of silicone breast implants for the first time
in 14 years. Revelations that have led to widespread scepticism as
to whether it is to soon for silicone...
The need for tighter regulations on the use of nanotechnologies in
unregulated cosmetic and pharmaceuticals was again called into
question at a meeting called by the US Food and Drug Administration
this week.
AGI Dermatics says it is testing a new drug, Dimericine, which it
claims can be incorporated into anti-ageing and sunscreen products
as a means of repairing uv-related damage already apparent in the
skin.
Basic Research has said it is working with the FDA following a
warning letter sent by the goverment regulation body stating that
marketing claims for its anti-wrinkle treatment, StriVectin-SD,
could mean the product's status...
Restylane is the third injectable wrinkle treatment to win approval
from the US Food and Drug Administration (FDA). The product is made
with hyaluronic acid, a substance normally found in the skin that
helps keep it plump. Already...
